Valuation: FDC Limited

Market Cap 52.29B 554M 486M 448M 419M 787M 803M 5.39B 2.08B 25.85B 2.08B 2.04B 89.62B P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 47.15B 500M 438M 404M 378M 709M 724M 4.85B 1.88B 23.3B 1.88B 1.84B 80.79B EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
30.05%
Yield 2024 *
-
Yield 2025 1.27%
1 day-0.57%
1 week+6.27%
Current month+0.81%
1 month+10.55%
3 months+23.76%
6 months-0.21%
Current year-3.50%
1 week 387.15
Extreme 387.15
421.5
1 month 373.25
Extreme 373.25
439.45
Current year 312.95
Extreme 312.95
439.45
1 year 312.95
Extreme 312.95
527.8
3 years 306.55
Extreme 306.55
658.85
5 years 225
Extreme 225
658.85
10 years 148.3
Extreme 148.3
658.85
Manager TitleAgeSince
Chief Executive Officer 90 2009-11-18
Chief Executive Officer 63 1993-09-29
Director of Finance/CFO - 2025-10-23
Director TitleAgeSince
Director/Board Member 48 2001-12-31
Director/Board Member 63 1993-09-29
Chairman 90 2009-11-15
Change 5-day change 1-year change 3-year change Capi.($)
-0.57%+6.27% - - 706M
+7.00%+9.05%+51.16%+165.45% 1,006B
+3.49%+9.52%+66.64%+54.80% 589B
+1.55%+7.21%+32.02%+82.73% 430B
-0.66%+5.11%+29.26%+21.27% 331B
+1.82%+8.19%+41.15%+26.80% 288B
+0.22%+6.75%+31.51%+42.02% 285B
+0.73%+8.53%-26.22%-40.85% 213B
+1.06%+3.51%+27.84%+58.78% 190B
+2.37%+1.49%+17.76%+65.54% 154B
Average +1.57%+5.96%+30.12%+52.95% 387.31B
Weighted average by Cap. +3.00%+5.38%+39.43%+78.47%

Financials

2024 2025
Net sales 19.43B 206M 181M 166M 156M 292M 298M 2B 774M 9.6B 773M 757M 33.3B 21.08B 223M 196M 181M 169M 317M 324M 2.17B 840M 10.42B 839M 821M 36.13B
Net income 3.05B 32.36M 28.37M 26.15M 24.48M 45.91M 46.86M 314M 122M 1.51B 121M 119M 5.23B 2.67B 28.28M 24.8M 22.86M 21.4M 40.13M 40.96M 275M 106M 1.32B 106M 104M 4.57B
Net Debt -4.55B -48.23M -42.28M -38.98M -36.49M -68.42M -69.85M -468M -181M -2.25B -181M -177M -7.8B -5.15B -54.59M -47.86M -44.12M -41.31M -77.45M -79.06M -530M -205M -2.55B -205M -201M -8.83B
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
26-06-25 ₹408.30 -0.57% 218,868
26-06-24 ₹410.65 -0.35% 412,325
26-06-23 ₹412.10 +2.13% 1,013,084
26-06-22 ₹403.50 +3.63% 449,704
26-06-19 ₹389.35 +1.34% 138,399
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B